Cargando…
Healthcare Utilization and Outcomes in Atrial Fibrillation Patients Treated by Drug Therapy versus a Catheter Ablation Strategy—A Middle European Propensity Score Matched Cohort Study
Background and Aims: Atrial fibrillation (AF) is the most prevalent arrhythmia, associated with increased mortality and morbidity and causing relevant costs. Treatment options consist of catheter ablation (PVI) and rate or rhythm control drugs (non-PVI). Methods: We analyze inpatient and outpatient...
Autores principales: | Martinek, Martin, Crijns, Harry J. G. M., Essers, Barbara A. B., Wiesinger, Rene, Pruckner, Gerald |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9781316/ https://www.ncbi.nlm.nih.gov/pubmed/36547448 http://dx.doi.org/10.3390/jcdd9120451 |
Ejemplares similares
-
Healthcare utilization and outcomes in atrial fibrillation patients treated by drug therapy versus a catheter ablation strategy
por: Martinek, M, et al.
Publicado: (2023) -
Catheter ablation of atrial fibrillation in patients with autoimmune disease: A propensity score matching study based on the China Atrial Fibrillation Registry
por: Gao, Ming‐Yang, et al.
Publicado: (2023) -
Hybrid thoracoscopic surgical and transvenous catheter ablation versus transvenous catheter ablation in persistent and longstanding persistent atrial fibrillation (HARTCAP-AF): study protocol for a randomized trial
por: Vroomen, Mindy, et al.
Publicado: (2019) -
Comparison of Amiodarone and Propafenone in Blanking Period after Radiofrequency Catheter Ablation in Patients with Atrial Fibrillation: A Propensity Score-Matched Study
por: Huang, RongDa, et al.
Publicado: (2020) -
Catheter Ablation for Atrial Fibrillation
por: Gauri, Andre J, et al.
Publicado: (2003)